| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
10,723 |
873 |
$297K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
9,730 |
594 |
$30K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,653 |
439 |
$8K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
3,900 |
340 |
$7K |
| A4657 |
Syringe, with or without needle, each |
637 |
503 |
$3K |
| 85048 |
|
341 |
330 |
$0.00 |
| 83970 |
|
245 |
231 |
$0.00 |
| 83540 |
|
143 |
138 |
$0.00 |
| 85041 |
|
340 |
329 |
$0.00 |
| 82108 |
|
13 |
13 |
$0.00 |
| 82728 |
|
141 |
136 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
156 |
127 |
$0.00 |
| 83550 |
|
143 |
138 |
$0.00 |
| 90674 |
|
12 |
12 |
$0.00 |
| 82306 |
|
41 |
41 |
$0.00 |